Menu
Back to Browse Journals » Integrated Blood Pressure Control
Integrated Blood Pressure Control
- View all (80)
- Volume 10, 2017 (3)
- Volume 9, 2016 (10)
- Volume 8, 2015 (7)
- Volume 7, 2014 (8)
- Volume 6, 2013 (15)
- Volume 5, 2012 (4)
- Volume 4, 2011 (8)
- Volume 3, 2010 (17)
- Volume 2, 2009 (5)
- Volume 1, 2008 (3)
Journal Articles:
- 80 records -
Preeclampsia and cardiovascular disease: interconnected paths that enable detection of the subclinical stages of obstetric and cardiovascular diseases
Valdés G
Integrated Blood Pressure Control 2017, 10:17-23
Published Date: 28 August 2017
Serum magnesium and calcium in preeclampsia: a comparative study at the Korle-Bu Teaching Hospital, Ghana
Owusu Darkwa E, Antwi-Boasiako C, Djagbletey R, Owoo C, Obed S, Sottie D
Integrated Blood Pressure Control 2017, 10:9-15
Published Date: 16 August 2017
Medication adherence and its associated factors among hypertensive patients attending the Debre Tabor General Hospital, northwest Ethiopia
Teshome DF, Bekele KB, Habitu YA, Gelagay AA
Integrated Blood Pressure Control 2017, 10:1-7
Published Date: 16 June 2017
Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial
Jensen GS, Lenninger M, Ero MP, Benson KF
Integrated Blood Pressure Control 2016, 9:95-104
Published Date: 13 October 2016
Current best practice in the management of hypertensive disorders in pregnancy
Townsend R, O’Brien P, Khalil A
Integrated Blood Pressure Control 2016, 9:79-94
Published Date: 27 July 2016
Lercanidipine/enalapril combination in the management of obesity-related hypertension
Grassi G
Integrated Blood Pressure Control 2016, 9:69-77
Published Date: 26 April 2016
Personalized medicine and treatment approaches in hypertension: current perspectives
Byrd JB
Integrated Blood Pressure Control 2016, 9:59-67
Published Date: 6 April 2016
Evaluation and treatment of hypertensive crises in children
Stein DR, Ferguson MA
Integrated Blood Pressure Control 2016, 9:49-58
Published Date: 16 March 2016
Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature
Fatureto-Borges F, Lorenzi-Filho G, Drager LF
Integrated Blood Pressure Control 2016, 9:43-47
Published Date: 15 March 2016
Probiotics and blood pressure: current insights
Upadrasta A, Madempudi RS
Integrated Blood Pressure Control 2016, 9:33-42
Published Date: 25 February 2016
Chronic resveratrol reverses a mild angiotensin II-induced pressor effect in a rat model
Gordish KL, Beierwaltes WH
Integrated Blood Pressure Control 2016, 9:23-31
Published Date: 28 January 2016
The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial
Ried K, Travica N, Sali A
Integrated Blood Pressure Control 2016, 9:9-21
Published Date: 27 January 2016
Clinical use of extended-release oral treprostinil in the treatment of pulmonary arterial hypertension
Pugliese SC, Bull TM
Integrated Blood Pressure Control 2016, 9:1-7
Published Date: 25 January 2016
Renal denervation for the management of resistant hypertension
Patel HC, Hayward C, Vassiliou V, Patel K, Howard JP, Di Mario C
Integrated Blood Pressure Control 2015, 8:57-69
Published Date: 3 December 2015
Comparison between treadmill and bicycle ergometer exercise tests in mild-to-moderate hypertensive Nigerians
Abiodun OO, Balogun MO, Akintomide AO, Adebayo RA, Ajayi OE, Ogunyemi SA, Amadi VN, Adeyeye VO
Integrated Blood Pressure Control 2015, 8:51-55
Published Date: 11 August 2015
Does home blood pressure monitoring improve patient outcomes? A systematic review comparing home and ambulatory blood pressure monitoring on blood pressure control and patient outcomes
Breaux-Shropshire TL, Judd E, Vucovich LA, Shropshire TS, Singh S
Integrated Blood Pressure Control 2015, 8:43-49
Published Date: 3 July 2015
Vasomotor sympathetic outflow in the muscle metaboreflex in low birth weight young adults
Chifamba J, Mbangani B, Chimhete C, Gwaunza L, Allen LA, Chinyanga HM
Integrated Blood Pressure Control 2015, 8:37-42
Published Date: 27 May 2015
Vitamin D status and hypertension: a review
Ke L, Mason RS, Kariuki M, Mpofu E, Brock KE
Integrated Blood Pressure Control 2015, 8:13-35
Published Date: 8 April 2015
Risk factors and effective management of preeclampsia
English FA, Kenny LC, McCarthy FP
Integrated Blood Pressure Control 2015, 8:7-12
Published Date: 3 March 2015
Nitric oxide dysregulation in the pathogenesis of preeclampsia among Ghanaian women
Adu-Bonsaffoh K, Antwi DA, Obed SA, Gyan B
Integrated Blood Pressure Control 2015, 8:1-6
Published Date: 19 February 2015
Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance
Ried K, Fakler P
Integrated Blood Pressure Control 2014, 7:71-82
Published Date: 9 December 2014
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan
Varagic J, Punzi H, Ferrario CM
Integrated Blood Pressure Control 2014, 7:61-70
Published Date: 26 November 2014
Optimal perioperative management of arterial blood pressure
Lonjaret L, Lairez O, Minville V, Geeraerts T
Integrated Blood Pressure Control 2014, 7:49-59
Published Date: 12 September 2014
Which thiazide to choose as add-on therapy for hypertension?
Barrios V, Escobar C
Integrated Blood Pressure Control 2014, 7:35-47
Published Date: 30 July 2014
Aortic stiffness: pathophysiology, clinical implications, and approach to treatment
Sethi S, Rivera O, Oliveros R, Chilton R
Integrated Blood Pressure Control 2014, 7:29-34
Published Date: 23 May 2014
Phases in development of an interactive mobile phone-based system to support self-management of hypertension
Hallberg I, Taft C, Ranerup A, Bengtsson U, Hoffmann M, Höfer S, Kasperowski D, Mäkitalo Å, Lundin M, Ring L, Rosenqvist U, Kjellgren K
Integrated Blood Pressure Control 2014, 7:19-28
Published Date: 7 May 2014
Recruited renin-containing renal microvascular cells demonstrate the calcium paradox regulatory phenotype
MacGriff S, Woo RE, Ortiz-Capisano MC, Atchison DK, Beierwaltes WH
Integrated Blood Pressure Control 2014, 7:9-17
Published Date: 13 January 2014
No association between perfluoroalkyl chemicals and hypertension in children
Geiger SD, Xiao J, Shankar A
Integrated Blood Pressure Control 2014, 7:1-7
Published Date: 13 January 2014
Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure
Danyel LA, Schmerler P, Paulis L, Unger T, Steckelings UM
Integrated Blood Pressure Control 2013, 6:153-161
Published Date: 22 November 2013
Management of patients with resistant hypertension: current treatment options
Kumar N, Calhoun DA, Dudenbostel T
Integrated Blood Pressure Control 2013, 6:139-151
Published Date: 22 October 2013
Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine
Funder JW
Integrated Blood Pressure Control 2013, 6:129-138
Published Date: 4 October 2013
Treating resistant hypertension: role of renal denervation
Urban D, Ewen S, Ukena C, Linz D, Böhm M, Mahfoud F
Integrated Blood Pressure Control 2013, 6:119-128
Published Date: 11 September 2013
Prevalence of hypertension and its risk factors in southwest Ethiopia: a hospital-based cross-sectional survey
Gudina EK, Michael Y, Assegid S
Integrated Blood Pressure Control 2013, 6:111-117
Published Date: 31 July 2013
Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease
Chandy D, Aronow WS, Banach M
Integrated Blood Pressure Control 2013, 6:101-109
Published Date: 9 July 2013
The TRINITY Study: distribution of systolic blood pressure reductions
Sugimoto DH, Chrysant SG, Melino M, Lee J, Fernandez V, Heyrman R
Integrated Blood Pressure Control 2013, 6:89-99
Published Date: 12 July 2013
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS)
Meredith PA, Elliott HL
Integrated Blood Pressure Control 2013, 6:79-87
Published Date: 25 June 2013
Current perspectives on combination therapy in the management of hypertension
Mallat SG, Itani HS, Tanios BY
Integrated Blood Pressure Control 2013, 6:69-78
Published Date: 17 June 2013
Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination
Hovater MB, Jaimes EA
Integrated Blood Pressure Control 2013, 6:59-67
Published Date: 14 June 2013
Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy
Ghoneim RA, Omar AK, Sebastian VJ, Kassab R, Akijian G, Hafiz M, Schmidt B
Integrated Blood Pressure Control 2013, 6:49-57
Published Date: 5 June 2013
Azilsartan/chlorthalidone combination therapy for blood pressure control
Cheng JW
Integrated Blood Pressure Control 2013, 6:39-48
Published Date: 27 May 2013
Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness
Sun CK
Integrated Blood Pressure Control 2013, 6:27-38
Published Date: 30 April 2013
Current perspectives on rosuvastatin
Hu M, Tomlinson B
Integrated Blood Pressure Control 2013, 6:15-25
Published Date: 18 April 2013
Efficacy and tolerability of a single-pill combination of telmisartan 80 mg and hydrochlorothiazide 25 mg according to age, gender, race, hypertension severity, and previous antihypertensive use: planned analyses of a randomized trial
Zhu D, Bays H, Gao P, Mattheus M, Voelker B, Ruilope LM
Integrated Blood Pressure Control 2013, 6:1-14
Published Date: 3 April 2013
Out-of-office blood pressure: from measurement to control
Baguet JP
Integrated Blood Pressure Control 2012, 5:27-34
Published Date: 16 May 2012
New treatment options in the management of hypertension: appraising the potential role of azilsartan medoxomil
Volpe M, Savoia C
Integrated Blood Pressure Control 2012, 5:19-25
Published Date: 12 March 2012
Efficacy and safety of prolonged-release melatonin for insomnia in middle-aged and elderly patients with hypertension: a combined analysis of controlled clinical trials
Lemoine P, Wade AG, Katz A, Nir T, Zisapel N
Integrated Blood Pressure Control 2012, 5:9-17
Published Date: 25 January 2012
Cardio classics revisited: focus on the role of amlodipine
Owen AJ, Reid CM
Integrated Blood Pressure Control 2012, 5:1-7
Published Date: 6 January 2012
Integrated control of hypertension by olmesartan medoxomil and hydrochlorothiazide and rationale for combination
Punzi HA
Integrated Blood Pressure Control 2011, 4:73-83
Published Date: 7 December 2011
Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
Zamorano J, Edwards J
Integrated Blood Pressure Control 2011, 4:55-71
Published Date: 15 November 2011
Challenges posed to the maternal circulation by pregnancy
Valdés G, Corthorn J
Integrated Blood Pressure Control 2011, 4:45-53
Published Date: 30 August 2011
Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients
Trachtman H
Integrated Blood Pressure Control 2011, 4:35-44
Published Date: 24 May 2011
Clinical utility of fixed-combination telmisartan–amlodipine in the treatment of hypertension
Segura J, Ruilope LM
Integrated Blood Pressure Control 2011, 4:27-34
Published Date: 19 May 2011
Long-term use and tolerability of irbesartan for control of hypertension
Forni V, Wuerzner G, Pruijm M, Burnier M
Integrated Blood Pressure Control 2011, 4:17-26
Published Date: 18 April 2011
Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review
Melpomeni Peppa, Maria Krania, Sotirios A Raptis
Integrated Blood Pressure Control 2011, 4:7-16
Published Date: 3 March 2011
A critical appraisal of the clinical effectiveness of a fixed combination of valsartan, amlodipine, and hydrochlorothiazide in achieving blood pressure goals
Cheryl L Laffer, Fernando Elijovich
Integrated Blood Pressure Control 2011, 4:1-5
Published Date: 19 January 2011
First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combination
Konstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al
Integrated Blood Pressure Control 2010, 3:163-170
Published Date: 1 December 2010
Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
Ijlal Uddin, Shakil Aslam
Integrated Blood Pressure Control 2010, 3:155-162
Published Date: 16 November 2010
Optimal management of hypertension in elderly patients
Maria Czarina Acelajado
Integrated Blood Pressure Control 2010, 3:145-153
Published Date: 11 November 2010
Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control
Haroon-Ur Rashid
Integrated Blood Pressure Control 2010, 3:133-144
Published Date: 5 October 2010
Is tetrahydrobiopterin a therapeutic option in diabetic hypertensive patients?
Alberto Francisco Rubio-Guerra, Hilda Vargas-Robles, Luz Maria Ramos-Brizuela, et al
Integrated Blood Pressure Control 2010, 3:125-132
Published Date: 29 September 2010
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes
Eduardo Pimenta, Suzanne Oparil
Integrated Blood Pressure Control 2010, 3:113-123
Published Date: 28 September 2010
Intravenous clevidipine for management of hypertension
Alma Rivera, Elsa Montoya, Joseph Varon
Integrated Blood Pressure Control 2010, 3:105-111
Published Date: 28 June 2010
Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
Jan Basile
Integrated Blood Pressure Control 2010, 3:91-104
Published Date: 21 June 2010
Impact of telmisartan in modifying vascular risk
Jean-Philippe Baguet, Olivier Ormezzano, Gilles Barone-Rochette
Integrated Blood Pressure Control 2010, 3:81-89
Published Date: 15 June 2010
Critical appraisal and pooled analysis of telmisartan alone or in combination with hydrochlorothiazide for achieving blood pressure goals
Satoshi Morimoto, Nobuyuki Takahashi, Tatsuyori Morita, et al
Integrated Blood Pressure Control 2010, 3:73-79
Published Date: 3 June 2010
Critical appraisal of the differential effects of antihypertensive agents on arterial stiffness
Francesca Kum, Janaka Karalliedde
Integrated Blood Pressure Control 2010, 3:63-71
Published Date: 4 June 2010
Fixed combinations in the pragmatic management of hypertension: focus on aliskiren and hydrochlorothiazide as a single pill
Michel Burnier
Integrated Blood Pressure Control 2010, 3:57-62
Published Date: 27 May 2010
Update on the role of candesartan in the optimal management of hypertension and cardiovascular risk reduction
Ikechi G Okpechi, Brian L Rayner
Integrated Blood Pressure Control 2010, 3:45-55
Published Date: 27 May 2010
Evidence-based approach for managing hypertension in type 2 diabetes
Gerti Tashko, Robert A Gabbay
Integrated Blood Pressure Control 2010, 3:31-43
Published Date: 24 May 2010
Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination
Giuseppe Derosa, Sibilla AT Salvadeo
Integrated Blood Pressure Control 2010, 3:21-30
Published Date: 19 May 2010
Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension – update on clinical utility
Vivencio Barrios, Carlos Escobar
Integrated Blood Pressure Control 2010, 3:11-19
Published Date: 10 May 2010
De-stiffening drug therapy and blood pressure control
Michel E Safar
Integrated Blood Pressure Control 2010, 3:1-9
Published Date: 29 January 2010
Current concepts in combination therapy for the treatment of hypertension: combined calcium channel blockers and RAAS inhibitors
Alberto F Rubio-Guerra, David Castro-Serna, Cesar I Elizalde Barrera, et al
Integrated Blood Pressure Control 2009, 2:55-62
Published Date: 23 November 2009
Valsartan combination therapy in the management of hypertension – patient perspectives and clinical utility
David T Nash, Michael S McNamara
Integrated Blood Pressure Control 2009, 2:39-54
Published Date: 28 October 2009
Can nocturnal hypertension predict cardiovascular risk?
Oded Friedman, Alexander G Logan
Integrated Blood Pressure Control 2009, 2:25-37
Published Date: 4 September 2009
Clinical approach in treatment of resistant hypertension
Jennifer Frank, David Sommerfeld
Integrated Blood Pressure Control 2009, 2:9-23
Published Date: 30 July 2009
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials
Cesare Cuspidi, Francesca Negri, Valentina Giudici, Anna Capra, et al.
Integrated Blood Pressure Control 2009, 2:1-8
Published Date: 26 June 2009
Cuff inflation during ambulatory blood pressure monitoring and heart rate
Mia Skov-Madsen, My Svensson, Jeppe Hagstrup Christensen
Integrated Blood Pressure Control 2008, 1:15-19
Published Date: 6 November 2008
Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study
Giray Kabakci, Nevres Koylan, Baris Ilerigelen, Omer Kozan, Kemalettin Buyukozturk on behalf of the ICEBERG Investigators
Integrated Blood Pressure Control 2008, 1:5-13
Published Date: 2 November 2008
Antihypertensive effects of astaxanthin
Hidekatsu Yanai, Kumie Ito, Hiroshi Yoshida, Norio Tada
Integrated Blood Pressure Control 2008, 1:1-3
Published Date: 27 October 2008